Tissue Regeneration & Repair
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT06918925
First-In-Human Study to Evaluate Single Ascending Doses of JUV-161 in Healthy Adult Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 14, 2025
Completion: Jun 30, 2026
Loading map...